Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool

Experimental Hematology

Volumn 30, Issue 5, 2002, Pages 410-420

  Hanenberg, Helmut ^a,b   Pollok, Karen E ^b,d   Vieten, Lydia ^a   Verlander, Peter C ^c   Leurs, Cordula ^a   Cooper, Ryan J ^b,d   Göttsche, Kerstin ^a   Haneline, Laura ^b   Clapp, D Wade ^b   Lobitz, Stephan ^a   Williams, David A ^b,d   Auerbach, Arleen D ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBRONECTIN; RETROVIRUS VECTOR;

ARTICLE; BLOOD CELL; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA CROSS LINKING; FANCONI ANEMIA; GENE IDENTIFICATION; GENE TRANSFER; GENETIC ANALYSIS; GENETIC COMPLEMENTATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; METAPHASE; NORTH AMERICA; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

3T3 CELLS; ANIMALS; B-LYMPHOCYTES; CELL LINE; CELL LINE, TRANSFORMED; CELL SURVIVAL; DNA-BINDING PROTEINS; ETHNIC GROUPS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; METAPHASE; MICE; MITOMYCIN; PROTEINS; RECOMBINANT PROTEINS; RETROVIRIDAE; T-LYMPHOCYTES; TRANSFECTION;

EID: 18444378426     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00782-8     Document Type: Article

References (67)

1. Fanconi anemia
2. Disorders of DNA replication and repair
3. Identification of two complementation groups in Fanconi anemia
4. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9
5. Classification of Fanconi anemia patients by complementation analysis: Evidence for a fifth subtype
6. Evidence for at least eight Fanconi anemia genes
7. Complementation analysis in Fanconi anemia: Re-assignment of the reference FA-H patient to group A
8. Positional cloning of a novel Fanconi anemia gene, FANCD2
9. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
10. Positional cloning of the Fanconi anaemia group A gene
11. Cloning of cDNAs for Fanconi's anaemia by functional complementation
12. Isolation of a cDNA representing the Fanconi anemia complementation group E gene
13. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM
14. The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells
15. The Fanconi anaemia group G gene FANCG is identical with XRCC9
16. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2
17. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression
18. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase
19. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex
20. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
21. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1
22. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews
23. Mutation analysis of the Fanconi anemia gene FACC
24. Carrier frequency of the IVS4+4 A >T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population
25. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: An International Fanconi Anemia Registry study
26. Novel mutations amd polymorphisms in the Fanconi anemia Group C gene
27. The Fanconi anemia mutation database
28. Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9
29. The del327 mutation in the Fanconi anemia group C gene generates a novel transcript lacking the first two coding exons
30. Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9
31. International Fanconi Anemia Registry (IFAR) update on patients in North America: Distribution of complementation groups and genotype phenotype correlations
32. The genomic organization of the Fanconi anemia group A (FAA) gene
33. Sequence variation in the Fanconi anemia gene FAA
34. Mutations of the Fanconi anemia group A gene (FAA) in Italian patients
35. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene
36. Identification of Alu-mediated deletions in the Fanconi anemia gene FAA
37. Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions
38. High frequency of large intragenic deletions in the Fanconi anemia group A gene
39. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
40. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments
41. Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus
42. International Fanconi Anemia Registry: Relation of clinical symptoms to diepoxybutane sensitivity
43. Versatile retroviral vectors for potential use in gene therapy
44. Correction of Fanconi anemia type C phenotypic abnormalities using a clinically-suitable retroviral infection protocol
45. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells
46. A safe packaging line for gene transfer: Separating viral genes on two different plasmids
47. Construction and use of a safe and efficient amphotropic packaging cell line
48. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
49. Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and G-CSF mobilized peripheral blood
50. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
51. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells
52. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation
53. Diagnosis of Fanconi anemia by diepoxybutane analysis
54. Is Fanconi anemia caused by a defect in the processing of DNA damage?
55. Complementation studies in Fanconi anemia
56. Somatic mosaicism in Fanconi anemia: Molecular basis and clinical significance
57. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope
58. Fanconi anemia diagnosis and the diepoxybutane (DEB) test
59. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C
60. Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer
61. Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer
62. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene
63. Flow cytometric testing for syndromes with chromosomal instability, aplastic anemia and related hematological disorders
64. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia
65. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells
66. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking